Research output per year
Research output per year
Personal profile
Research interests
My primary research interest is the origins of childhood lung disease, particularly the pathophysiology of CF lung disease in infancy and early childhood.
Clinical interests
Early childhood lung disease, cystic fibrosis, primary ciliary dyskinesia, asthma, pulmonary function testing, infant pulmonary function testing, multiple breath washout testing.
Fingerprint
Dive into the research topics where Jessica Pittman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Airway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and Genotype
Kinghorn, B. A., Rosenfeld, M., Sullivan, E., Onchiri, F., Ferkol, T. W., Sagel, S. D., Dell, S. D., Milla, C., Shapiro, A. J., Sullivan, K. M., Zariwala, M. A., Pittman, J. E., Mollica, F., Tiddens, H. A. W. M., Kemner-van de Corput, M., Knowles, M. R., Davis, S. D. & Leigh, M. W., Apr 1 2023, In: Annals of the American Thoracic Society. 20, 4, p. 539-547 9 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI
Promise Study Group, Schwarzenberg, S. J., Vu, P. T., Skalland, M., Hoffman, L. R., Pope, C., Gelfond, D., Narkewicz, M. R., Nichols, D. P., Heltshe, S. L., Donaldson, S. H., Frederick, C. A., Kelly, A., Pittman, J. E., Ratjen, F., Rosenfeld, M., Sagel, S. D., Solomon, G. M., Stalvey, M. S. & Clancy, J. P. & 2 others, , Mar 2023, In: Journal of Cystic Fibrosis. 22, 2, p. 282-289 8 p.Research output: Contribution to journal › Article › peer-review
Open Access49 Scopus citations -
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis A Clinical Trial
the PROMISE Study Group, Mar 1 2022, In: American journal of respiratory and critical care medicine. 205, 5, p. 529-539 11 p.Research output: Contribution to journal › Article › peer-review
Open Access194 Scopus citations -
Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas
Pittman, J. E., Skalland, M. S., Sagel, S. D., Ramsey, B. W., Mayer-Hamblett, N. & Retsch-Bogart, G. Z., Nov 2022, In: Journal of Cystic Fibrosis. 21, 6, p. 946-949 4 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial
TEACH Study Group, Jun 2022, In: Thorax. 77, 6, p. 581-588 8 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations